Lootens, O.; De Boevre, M.; Gasthuys, E.; De Saeger, S.; Van Bocxlaer, J.; Vermeulen, A.
Exploring the Impact of Efavirenz on Aflatoxin B1 Metabolism: Insights from a Physiologically Based Pharmacokinetic Model and a Human Liver Microsome Study. Toxins 2024, 16, 259.
https://doi.org/10.3390/toxins16060259
AMA Style
Lootens O, De Boevre M, Gasthuys E, De Saeger S, Van Bocxlaer J, Vermeulen A.
Exploring the Impact of Efavirenz on Aflatoxin B1 Metabolism: Insights from a Physiologically Based Pharmacokinetic Model and a Human Liver Microsome Study. Toxins. 2024; 16(6):259.
https://doi.org/10.3390/toxins16060259
Chicago/Turabian Style
Lootens, Orphélie, Marthe De Boevre, Elke Gasthuys, Sarah De Saeger, Jan Van Bocxlaer, and An Vermeulen.
2024. "Exploring the Impact of Efavirenz on Aflatoxin B1 Metabolism: Insights from a Physiologically Based Pharmacokinetic Model and a Human Liver Microsome Study" Toxins 16, no. 6: 259.
https://doi.org/10.3390/toxins16060259
APA Style
Lootens, O., De Boevre, M., Gasthuys, E., De Saeger, S., Van Bocxlaer, J., & Vermeulen, A.
(2024). Exploring the Impact of Efavirenz on Aflatoxin B1 Metabolism: Insights from a Physiologically Based Pharmacokinetic Model and a Human Liver Microsome Study. Toxins, 16(6), 259.
https://doi.org/10.3390/toxins16060259
